ATARA Biotherapeutics (ATRA) Misses Q4 EPS by 27c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q4 EPS of ($0.96), $0.27 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AXT appoints Tracy Liu to its board of directors
• Worried the AI trade has gone too far? Evercore likes these 4 stocks